View Author
Kok, T.C.
(Tjebbe Kok)
patient cancer chemotherapy esophageal surgery carcinoma treatment study response cisplatin esophagus esophageal cancer trial chapter disease preoperative chemotherapy survival tumor group month preoperative resection cell carcinoma tumour phase etoposide result adenocarcinoma toxicity expression phase ii study table esophageal carcinoma cs group therapy cycle combination course radiotherapy metastase metastatic randomized 5- fluorouracil oncol cell cancer lymph phase ii trial fluorouracil staining grade splinter protein range percent splinter taw response rate analysis papillomaviru evaluation stage kok tc radiation bleomycin junction oesophageal mrp expression 13- cis-retinoic acid activity resistance number multidrug tumours regimen biopsy gaast effect agent folinic acid lesion multidrug resistance-associated protein
2 Most Recent Publications
|
Chemotherapy followed by surgery versus surgery alone in patients with resectable oesophageal squamous cell carcinoma: Long-term results of a randomized controlled trial
(Article)
Boonstra, J.J. Kok, T.C. Siersema, P.D. Wijnhoven, B.P.L. Heijl, M. van Berge Henegouwen, M.I. van Kate, F.J.W. ten Dinjens, W.N.M. Lanschot, J.J.B. van Tilanus, H.W. Gaast, A. van der |
2011-05-19
|
|
Chemotherapy in cancer of the esophagus
(Doctoral Thesis)
Kok, T.C. |
1997-10-22
|
